ETHEREUM: A SECURE DECENTRALISED GENERALISED TRANSACTION ...
Ethereum (ETH) Altcoin: trusted ratings and reviews from ...
Ethereum - Journal du Coin
Actualités Ethereum - Journal du Coin
Disrupting the $23.5 billion science publishing industry with blockchain technology
Start up developing a software platform on which institutions such as research funders and universities can launch their own open access peer review journal. We are combining the know-how from the Swiss open access science publisher ScienceMatters.io and blockchain expertise from the University of Zurich to create a platform which will have a tokenised ecosystem and which will record each manuscript and its rating with unique hashes on Ethereum.
This article from "Ethereum World News" gets basic details wrong about how Ethereum works. Crypto journalism in its current state is a complete joke.
The Article Ignoring the fact that there is absolutely zero useful content in this article, a quote near the bottom makes zero sense.
Interestingly, if the value were to drop below $140 and make it unprofitable for miners, the mining would stop, and the supply of ETH tokens would reduce. That would create more demand for Ethereum and ultimately cause a bullish run.
Nick James: I'm publicly shaming you for having absolutely no clue what you are talking about.
Would an ethereum based academic journal be feasible?
I'm trying to understand the scope and potential of dapps, and came up with the idea of a peer reviewed journal that lived on the etherum block chain. Partly because academic journals are kind of a racket at the moment and decentralizing the process is in the global interest (they charge exorbitant fees, but neither the authors nor the reviewers are payed). I assume using the blockchain as a file store is infeasible, but maybe as a way of verifying that an article had passed a review process, and then somehow making that article available for a small transaction fee? I'm not really sure how this would work beyond that, as I am just learning about this stuff.
The Dow fell 632.42, or 2.25%, to 27,500.89, the Nasdaq lost 465.944, or 4.11%, to 10,847.69, and the S&P 500 declined 95.12, or 2.78%, to 3,331.84. The major averages were sharply lower in Tuesday's trading, picking up where they left off before the long holiday weekend. Tech once again was leading the charge lower, with the Nasdaq the laggard among the major averages. Today's selling was largely a continuation of last week, but unlike Friday, buyers appeared unwilling to buy the dip. Tesla's 21% decline was a drag on the Nasdaq, while Apple's 7% decline pressured the large-cap indices and the S&P 500 information technology sector (-4.6%). The energy (-3.7%) and financials (-2.6%) sectors followed suit amid weaker oil prices ($36.76/bbl, -2.94, -7.4%) and lower Treasury yields, while the utilities sector (-0.6%) declined the least. Besides concerns that the market's pullback had more room to go, investors had to contend with Democratic leadership rebuffing the Senate's $300 billion coronavirus relief bill, President Trump suggesting disincentives for U.S. companies to outsource jobs to China, and reports that China's largest semiconductor foundry could be added to a trade blacklist. Production problems at a BA 787 Dreamliner factory have prompted air-safety regulators to review quality-control lapses potentially stretching back almost a decade, The Wall Street Journal reported over the weekend. This morning, Boeing said in a statement to media outlets that inspections stemming from production problems of its 787 Dreamliners are slowing deliveries. AAPL announced an event, to be held from Apple Park on September 15, without offering details on the nature or contents of the meeting. Bloomberg is reporting the event will be focused on the iPad, not the company's new iPhone models. The prospect of potential retaliation on U.S. semiconductor companies was an additional drag on the Philadelphia Semiconductor Index (-4.7%). Separately, Boeing (BA 161.08, -9.97, -5.8%) provided a disappointing update, saying 787 Dreamliner production problems have slowed the pace of deliveries. Among the noteworthy gainers was NKLA, which surged +40.8% after GM, +7.9% formed a strategic partnership that was well-received by investors. WDIS, +1.7% was upgraded to Buy from Hold at Deutsche Bank. Among the notable losers was CRBP, which fell 74% after its RESOLVE-1 Phase 3 study did not meet its primary endpoint. Also lower was ACMR, which declined 26% after Needham analyst N. Quinn Bolton downgraded the stock to Hold from Buy, saying that the company's business outlook could weaken due to its "material exposure" to Chinese chip giant SMIC. The downgrade follows reports that the Pentagon proposed for SMIC to be added to U.S. government trade blacklist. U.S. Treasuries saw increased buying interest amid the decline in equities but closed off highs. The 2-yr yield declined two basis points to 0.14%, and the 10-yr yield declined four basis points to 0.68%. The U.S. Dollar Index rose 0.8% to 93.46. Oil prices were pressured by Saudi Aramco lowering its prices for buyers in Asia and the U.S. due to sluggish demand. Elsewhere, Stoxx 600 provisionally closed over 1% lower, with the tech sector falling another 2% as almost all sectors and major bourses fell into negative territory. Stocks in Asia-Pacific were higher on Tuesday, as Japan released revised gross domestic product figures for the second quarter.
The U.S. Dollar Index climbed 0.8% to 93.46, recording its sixth consecutive advance. In emerging markets, Turkey’s lira hit another record low and Russia’s rouble sagged to its lowest since April amid ongoing talk about fresh Western sanctions.
EUUSD: -0.3% to 1.1777
GBP/USD: -1.3% to 1.2988
USD/CNH: +0.3% to 6.8537
USD/JPY: -0.2% to 106.03
Treasuries overtook their opening levels as the stock market opened for the day, but the buying pressure faded shortly thereafter, allowing Treasuries to inch back to their starting levels as the day went on. Today's $50 bln 3-yr note auction was met with lukewarm demand but Treasuries of most tenors remained near their midday levels into the close.
2-yr: -2 bps to 0.14%
3-yr: -1 bp to 0.17%
5-yr: -3 bps to 0.27%
10-yr: -4 bps to 0.68%
30-yr: -5 bps to 1.42%
WTI crude futures settled sharply lower by 7.4%, or $2.94, to $36.76/bbl. Prices were pressured by Saudi Arabia reducing October prices for buyers in Asia and the U.S. Gold futures settled $8.90 higher (+0.5%) to $1,943.20/oz, recouping earlier declines, as pressure from equities pushed investors into the yellow metal. Gold’s gains came despite a stronger dollar, which rose 0.7% against rivals. Investors are now awaiting an ECB policy meeting due on Thursday, while the U.S. Federal Reserve’s next meeting is scheduled for next week.
WTI crude: -7.4% to $36.76/bbl
Gold: +0.5% to $1943.10/ozt
Copper: -1.3% to $3.023/lb
Bitcoin is again proving itself to be a bit too correlated with financial markets for comfort, continuing to slide right alongside stocks.
Bitcoin: $10,035.96 (24hr: -1.15%)
Ethereum: $337.05 (24hr: -2.62%)
Ripple: $0.23 (24hr: -0.06%)
FAAMG + some penny stocks +20.9% YTD
Spoos +3.1% YTD
Old man -3.6% YTD
Russy -9.7% YTD
In COVID-19 news, Florida reported 650,092 cases of the virus versus 648,269 the previous day, while California reported a 2,676 increase in cases from the prior day. The CEOs of AZN, BNTX, GSK, JNJ, MRK, MRNA, NVAX, PFE and SNY announced a pledge, outlining a "united commitment to uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines." The statement reads in part: "We, the undersigned biopharmaceutical companies, want to make clear our on-going commitment to developing and testing potential vaccines for COVID-19 in accordance with high ethical standards and sound scientific principles. The safety and efficacy of vaccines, including any potential vaccine for COVID-19, is reviewed and determined by expert regulatory agencies around the world, such as the United States Food and Drug Administration. FDA has established clear guidance for the development of COVID-19 vaccines and clear criteria for their potential authorization or approval in the US. FDA's guidance and criteria are based on the scientific and medical principles necessary to clearly demonstrate the safety and efficacy of potential COVID-19 vaccines. More specifically, the agency requires that scientific evidence for regulatory approval must come from large, high quality clinical trials that are randomized and observer-blinded, with an expectation of appropriately designed studies with significant numbers of participants across diverse populations...We believe this pledge will help ensure public confidence in the rigorous scientific and regulatory process by which COVID-19 vaccines are evaluated and may ultimately be approved. We believe this pledge will help ensure public confidence in the rigorous scientific and regulatory process by which COVID-19 vaccines are evaluated and may ultimately be approved." The companies also pledged to "only submit for approval or emergency use authorization after demonstrating safety and efficacy through a Phase 3 clinical study that is designed and conducted to meet requirements of expert regulatory authorities such as FDA."
Slack Technologies EPS beats by $0.03, beats on revenue. Reports paying customers of 130k +30%. Shares down by 15%.
Snowflake prices $75-85 IPO with Salesforce, Berkshire Hathaway set to buy
Lululemon slips after earnings beat, execs cautiously optimistic on back half
Get the latest and hottest cryptocurrency industry, Bitcoin, Ethereum, blockchain, cryptocurrency prices and more at Coinjournal.co 2e cryptomonnaie après Bitcoin, Ethereum tient une place très importante dans le crypto-écosystème. Suivez l'actualité Ethereum sur le Journal du Coin. Ethereum is a blockchain platform and Ether is the token that powers the network built on that platform. The novelist L.M. Montgomery once wrote, “It’s dreadful what little things lead people to misunderstand each other.” Ethereum is a global, decentralized platform for money and new kinds of applications. On Ethereum, you can write code that controls money, and build applications accessible anywhere in the world. But Ethereum builds on the Bitcoin platform, and improves many of its original offerings, by harnessing the blockchain capability with superior codes and algorithms. Ethereum allows for scripts of code to be run as a global computational network, which means that the project is ultimately considerably more flexible than Bitcoin.
Analyse de Marché #13 : EOS, NEO, BITCOIN, ETHEREUM
Bitcoin Ethereum Litecoin BCH Technical Analysis Chart 7/11/2018 by ChartGuys.com ... Journal du Coin 3,300 views. 9:08. BITCOIN : ATTENTION À LA DEATH CROSS ! - Duration: 18:16. Journal du ... Ethereum 2.0 Phase 0 Testnet Release went live on May 7th. Transition from Proof of Work (PoW) to Proof of Stake has been mentioned by Vitalik many times throughout the past 2 years. Finally, they ... 5 OUTILS pour développer des DAPPS sur ETHEREUM - Duration: 6:40. Journal du Coin 1,390 views. 6:40. Solidity Tutorial - A Full Course on Ethereum, Blockchain Development, Smart Contracts, ... Deep In Your Mind Deep House Set Winter 2017 Mixed By Johnny M - Duration: 1:11:46. Johnny M In The Mix Dj Activities Recommended for you -- titres -- journal du crypto #4:🛑uniswap air drop!ethereum, tezos, polkadot, iexec. rappel on est sur theta -- news -- cela avance du cÔtÉ d’ethereum https...